DBV Technologies SAEURONEXT: DBV

DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre

· Issued by DBV Technologies SA via Euronext

Filed with Euronext · · 2 pages · French

Summary by 6ix AI

DBV Technologies announces its participation in several investor conferences in September. The company will attend the Cantor Global Healthcare Conference on September ninth. DBV Technologies is a biopharmaceutical company focused on developing treatments for food allergies and other immunological conditions. The company is currently studying the use of its VIASKIN® patch technology for treating food allergies.

Written in English by 6ix AI from the company’s French-language filing. How 6ix writes summaries

DBV Technologies SA on 6ix

Earlier from DBV Technologies

Later from DBV Technologies

All DBV Technologies news releases